SCHEMBL6340214

SCHEMBL6340214

COC(=O)c1ccc2c(=O)c3c(C)nn(-c4ccccn4)c3[nH]c2c1

nearest known ligand 0.48

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
DYRK1A Q13627 1/20 0.47
PARP1 P09874 2/20 0.46
KIF11 P52732 1/20 0.46
ALDH1A1 P00352 5/20 0.42
SMN1; SMN2 Q16637 3/20 0.42
KMT2A Q03164 3/20 0.42
MEN1 O00255 2/20 0.42
GAA P10253 3/20 0.42
CSNK2A1 P68400 1/20 0.42
POLB P06746 1/20 0.42
TSHR P16473 1/20 0.42
KDM4E B2RXH2 4/20 0.42
HPGD P15428 3/20 0.42
HSD17B10 Q99714 1/20 0.42
IMPDH2 P12268 1/20 0.40
MAPT P10636 1/20 0.40
HTT P42858 1/20 0.40
NPSR1 Q6W5P4 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6350724 0.92 KDM4E (0.44) DYRK1AKIF11ALDH1A1SMN1; SMN2KMT2A
SCHEMBL6345178 0.89 DYRK1A (0.45) DYRK1APARP1ALDH1A1GAAKDM4E
SCHEMBL6344842 0.83 SPR (0.43)
SCHEMBL6342655 0.82 SPR (0.43) PARP1ALDH1A1KMT2AMEN1KDM4E
SCHEMBL6344363 0.82 MAPT (0.43) DYRK1AALDH1A1SMN1; SMN2KDM4EHPGD
SCHEMBL6353735 0.81 SPR (0.42) DYRK1AALDH1A1GAAKDM4EHPGD
SCHEMBL6339985 0.81 L3MBTL1 (0.43) ALDH1A1SMN1; SMN2KMT2AHPGDHSD17B10
SCHEMBL6342844 0.81 ALDH1A1 (0.44) ALDH1A1SMN1; SMN2KMT2AMEN1KDM4E
SCHEMBL6345281 0.80 ALDH1A1 (0.46) ALDH1A1SMN1; SMN2KMT2AMEN1GAA
SCHEMBL6343219 0.79 L3MBTL1 (0.40) ALDH1A1SMN1; SMN2KMT2AMEN1GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6949648-B2 Condensed pyrazole derivatives, process for producing the same and use thereof TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2005-09-27 US disclosed
US-20030187014-A1 Condensed pyrazole derivatives, process for producing the same and use thereof TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2003-10-02 US disclosed
EP-1270572-A1 CONDENSED PYRAZOLE DERIVATIVES, PROCESS FOR PRODUCING THE SAME AND USE THEREOF TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 2003-01-02 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030187014-A1 Condensed pyrazole derivatives, process for producing the same and use thereof PTGS1, PTGIS, IL5 DYRK1A 4242/4885PARP1 3752/4885KIF11 3103/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.